BeStock  
Stocks › Biotechnology › BNTX

BioNTech BNTX

US equityMarket cap rank #505BiotechnologyInfectious Disease
$97.40 −$0.90 (-0.92%)
Market open · Oct 1, 1:20 pm ET · After hours $98.30 0.00%
Open$97.59
Prev close$98.30
Day range$97.13 – $99.41
Volume306.6K
Market cap$24.47B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026 · reported in EUR

Revenue€105.60M-59.5% YoY
Operating profit-€938.70M-98.9% YoY
Net profit-€820.80M-112.3% YoY
Diluted EPS-€3.24-102.5% YoY
Free cash flow-€44.90M-138.6% YoY
Operating cash flow€10.50M

Revenue, last 8 quarters

€1.2BSep '24€1.2BDec '24€182.8MMar '25€260.8MJun '25€1.5BSep '25€907.4MDec '25€118.1MMar '26€105.6MJun '26

Net profit, last 8 quarters

€198.1MSep '24€259.5MDec '24€-415.8MMar '25€-386.6MJun '25€-28.7MSep '25€-305.0MDec '25€-531.9MMar '26€-820.8MJun '26

Diluted EPS by quarter

0.81Sep '241.08Dec '24-1.73Mar '25-1.60Jun '25-0.12Sep '25-1.25Dec '25-2.10Mar '26-3.24Jun '26

Free cash flow by quarter

€-721.9MSep '24€-554.4MDec '24€-1.4BMar '25€116.3MJun '25€742.1MSep '25€247.4MDec '25€-499.9MMar '26€-44.9MJun '26

Annual revenue

€482.3MFY20€19.0BFY21€17.3BFY22€3.8BFY23€2.8BFY24€2.9BFY25

Profitability & balance sheet

Gross margin75.5%
Operating margin-46.4%
Net margin-63.6%
Return on equity-9.3%
Return on assets-8.0%
Return on invested capital-9.1%
Current ratio7.85
Liabilities / assets12.7%
Cash & investments€14.78B
Total debt€316.10M
Net cash (debt)€14.46B
Free cash flow / sales16.8%

This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.

Income statement

Line item 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
Total Revenue as Reported €105.60M €118.10M €2.87B €907.40M €1.52B
Total Operating Revenue €105.60M €118.10M €2.87B €907.40M €1.52B
Cost of Revenue €97.00M €71.40M €641.80M €333.30M €148.30M
Gross Profit €8.60M €46.70M €2.23B €574.10M €1.37B
Operating Expense €947.30M €717.90M €2.87B €854.60M €716.70M
Selling and Admin Expenses €197.80M €163.80M €698.20M €291.70M €148.50M
-Selling & Marketing Expense €40.10M €27.90M €110.00M €49.30M €27.30M
-General & Admin Expense €157.70M €135.90M €588.20M €242.40M €121.20M
Research & Development €551.00M €557.00M €2.10B €505.40M €564.80M
Other Operating Expenses €198.50M -€2.90M €65.70M €57.50M €3.40M
Operating Profit -€938.70M -€671.20M -€640.70M -€280.50M €653.90M
Net Non-Operating Interest Income (Expense) €62.70M €57.00M -€12.60M -€5.10M -€300,000.00
Non-Operating Interest Income €66.40M €61.70M – – €100,000.00
Non-Operating Interest Expense €3.50M €4.00M €14.20M – –
Total Other Finance Costs €200,000.00 €700,000.00 -€1.60M -€9.30M €400,000.00
Other Income (Expense) €17.30M €46.10M -€397.50M €58.20M -€628.90M
Gain on Sale of Security €24.40M €46.40M €383.40M €110.30M €65.60M
Special Income (Charges) -€7.10M -€300,000.00 -€780.90M -€52.10M -€694.50M
-Less:Restructuring and Mergern & Acquisition €0.00 €0.00 -€15.00M €0.00 €0.00
-Less:Other Special Charges €7.10M – €789.50M €45.70M €694.50M
-Less:Write Off €0.00 €300,000.00 €6.40M – –
Pretax Profit -€858.70M -€568.10M -€1.05B -€227.40M €24.70M
Tax -€37.90M -€36.20M €85.30M €77.60M €53.40M
Net Profit -€820.80M -€531.90M -€1.14B -€305.00M -€28.70M
Profit from Continuing Operations -€820.80M -€531.90M -€1.14B -€305.00M -€28.70M
Net Income to Parent Company -€820.80M -€531.90M -€1.14B -€305.00M -€28.70M
Net Income to Common Stockholders -€820.80M -€531.90M -€1.14B -€305.00M -€28.70M
Basic EPS -€3.24 -€2.10 -€4.70 -€1.25 -€0.12
Diluted EPS -€3.24 -€2.10 -€4.70 -€1.25 -€0.12

Balance sheet

Line item 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
Total Assets €20.34B €21.07B €21.99B €21.99B €21.34B
Total Current Assets €15.30B €15.53B €16.15B €16.15B €15.83B
Cash and Cash Equivalents & Short-Term Investments €14.78B €14.64B €14.88B €14.88B €14.52B
-Cash and Cash Equivalents €9.74B €9.94B €7.68B €7.68B €10.09B
-Short Term Investments €5.04B €4.70B €7.20B €7.20B €4.43B
Receivables €245.20M €612.20M €984.90M €984.90M €784.50M
-Accounts Receivable €163.90M €539.20M €924.20M €924.20M €690.80M
-Taxes Receivable €70.90M €64.10M €52.60M €52.60M €84.80M
-Other Receivables €10.40M €8.90M €8.10M €8.10M €8.90M
Inventory €100.60M €103.80M €110.70M €110.70M €225.70M
Other Current Assets €172.70M €176.60M €173.80M €173.80M €292.90M
Total Non-Current Assets €5.05B €5.54B €5.84B €5.84B €5.51B
Net PPE €1.22B €1.32B €1.29B €1.29B €1.24B
-Gross PPE €1.22B €1.32B €1.77B €1.77B €1.24B
Investments and Advances €2.01B €2.28B €2.55B €2.55B €2.48B
-Available for Sale Securities €2.01B €2.21B €2.55B €2.55B €2.43B
Goodwill and Other Intangible Assets €1.79B €1.92B €1.97B €1.97B €1.75B
-Goodwill €373.30M €370.50M €367.90M €367.90M €357.70M
-Other Intangible Assets €1.42B €1.55B €1.61B €1.61B €1.39B
Non-Current Deferred Assets €15.70M €14.70M €13.50M €13.50M €17.70M
Other Non-Current Assets €10.30M €12.20M €7.30M €7.30M €24.60M
Total Liabilities €2.59B €2.38B €2.76B €2.76B €2.86B
Total Current Liabilities €1.95B €1.77B €2.14B €2.14B €2.22B
Payables €667.90M €506.90M €600.50M €600.50M €406.10M
-Accounts Payable €646.70M €468.80M €534.90M €534.90M €399.80M
-Total Tax Payable €21.20M €38.10M €65.60M €65.60M €6.30M
Short-Term Debt and Capital Lease Obligation €57.20M €56.70M €52.20M €52.20M €53.40M
-Current Debt €57.20M €10.80M €52.20M €52.20M €53.40M
Current Provisions €234.90M €167.00M €145.30M €145.30M €211.50M
Current Deferred Liabilities €742.50M €758.50M €754.90M €754.90M €796.10M
Other Current Liabilities €246.70M €275.90M €589.40M €589.40M €755.40M
Total Non-Current Liabilities €635.90M €611.30M €622.10M €622.10M €641.30M
Long Term Debt and Capital Lease Obligation €258.90M €246.10M €215.20M €215.20M €192.00M
-Long Term Debt €258.90M €66.60M €215.20M €215.20M €192.00M
Non-Current Liabilities €58.60M €23.80M €35.50M €35.50M €24.20M
Non-Current Deferred Liabilities €120.90M €140.60M €172.30M €172.30M €243.20M
Other Non-Current Liabilities €197.50M €200.80M €199.10M €199.10M €181.90M
Total Equity €17.76B €18.70B €19.22B €19.22B €18.48B
Stockholders' Equity €17.76B €18.70B €19.22B €19.22B €18.48B
Capital Stock €259.00M €259.00M €259.00M €259.00M €248.60M
-Common Stock €259.00M €259.00M €259.00M €259.00M €248.60M
Additional Paid-In Capital €2.34B €2.47B €2.47B €2.47B €1.45B
Retained Earnings €16.61B €17.43B €17.96B €17.96B €18.27B
Less: Treasury Stock €7.80M €6.10M €7.70M €7.70M €8.10M
Gains/Losses Not Affecting Retained Earnings -€1.44B -€1.45B -€1.46B -€1.46B -€1.48B
-Current Capital Lease Obligation – €45.90M – – –
-Long Term Capital Lease Obligation – €179.50M – – –
-Accumulated Depreciation – – -€475.50M -€475.50M –
Non Current Accounts Receivables – – €2.00M €2.00M €3.90M
Financial Assets – – – – €0.00
Derivative Product Liabilities – – – – €0.00

Cash flow

Line item 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
Operating Cash Flow €10.50M -€421.00M €456.00M €309.50M €780.70M
Net cash flow from continuing operations €10.50M -€421.00M €456.00M €309.50M €780.70M
Net Income from Continuing Operations -€858.70M -€568.10M -€1.05B -€227.40M €24.70M
Gain/Loss from Continuing Operations €16.40M €300,000.00 -€19.50M -€41.30M -€9.70M
Depreciation & Depletion & Amortization €266.10M €121.30M €382.80M €164.80M €124.20M
Other Non-Cash Items -€80.50M -€105.20M €169.70M €517.20M -€101.90M
Change in Working Capital €593.90M €66.20M €537.80M -€227.40M €644.00M
-Change in Receivables €366.00M €431.10M €1.08B €81.00M €881.70M
-Change in Inventory €3.20M €7.00M €177.90M €116.20M €5.10M
-Change in Payables and Accrued Expense €224.70M -€371.90M -€723.80M -€424.60M -€242.80M
Net cash flow from investing -€100.10M €2.65B -€2.47B -€2.73B -€925.30M
Net Cash Flow from Continuing Investing Activities -€100.10M €2.65B -€2.47B -€2.73B -€925.30M
Net PPE Purchase and Sale -€51.20M -€55.20M -€170.60M -€62.60M -€33.00M
Net Intangibles Purchase and Sale -€800,000.00 -€22.10M -€573.90M €1.10M -€2.70M
Net Business Purchase and Sale €0.00 €0.00 €186.30M €264.80M €0.00
Net Investment Purchase and Sale -€48.10M €2.73B -€1.91B -€2.93B -€889.60M
Financing Cash Flow -€108.50M €26.40M -€52.90M -€14.30M -€11.50M
Net Cash Flow from Continuing Financing Activities -€108.50M €26.40M -€52.90M -€14.30M -€11.50M
Net Issuance Payments Of Debt €20.70M €26.40M -€50.90M -€12.30M -€11.50M
Net Common Stock Issuance -€129.20M – €0.00 – –
Ending Cash Balance €9.74B €9.94B €7.68B €7.68B €10.09B
Net Change in Cash -€198.10M €2.26B -€2.07B -€2.43B -€156.10M
Beginning Cash Balance €9.94B €7.68B €9.76B €10.09B €10.27B
Effect of Exchange Rate Changes -€3.30M -€3.40M -€27.00M €1.40M -€21.50M
Free Cash Flow -€44.90M -€499.90M -€293.00M €247.40M €742.10M
Net Other Financing Charges – – -€2.00M – –

Discussion

No comments yet — be the first to weigh in on BNTX.

Leave a comment

Scroll to Top